Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 20.30 is 214% above its 5-year average of 6.46, near the high end of its 5-year range (0.54–20.30).
As of the fiscal period ended Tuesday, June 30, 2026. 153.04% above its 12-month average of 8.02.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 20.30.
QUICK RATIO (ACID-TEST)
20.30
QUICK RATIO (ACID-TEST) AVG TTM
8.02
QUICK RATIO (ACID-TEST) AVG 3Y
5.24
QUICK RATIO (ACID-TEST) AVG 5Y
6.46
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+153.04%
CURRENT VS 3Y AVG
+287.22%
CURRENT VS 5Y AVG
+214.19%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.32
median of 859 covered companies
CURRENT VS SECTOR MEDIAN
+511.48%
vs the sector median at left
Q32 Bio Inc.
Market Cap
$238.71M
Quick Ratio (Acid-Test)
20.30
TTM Avg
8.02
3Y Avg
5.24
5Y Avg
6.46
Market Cap
$238.51M
Quick Ratio (Acid-Test)
5.86
TTM Avg
4.06
3Y Avg
6.91
5Y Avg
7.76
Market Cap
$237.69M
Quick Ratio (Acid-Test)
0.81
TTM Avg
0.81
3Y Avg
0.76
5Y Avg
0.71
Market Cap
$235.87M
Quick Ratio (Acid-Test)
17.19
TTM Avg
13.55
3Y Avg
8.08
5Y Avg
8.08
Market Cap
$236.39M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.13
3Y Avg
1.14
5Y Avg
1.18
Market Cap
$241.04M
Quick Ratio (Acid-Test)
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$235.79M
Quick Ratio (Acid-Test)
44.27
TTM Avg
28.93
3Y Avg
23.00
5Y Avg
20.76
Market Cap
$242.23M
Quick Ratio (Acid-Test)
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.59
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $238.71M | 20.30 | 8.02 | 5.24 | 6.46 |
| Invivyd, Inc. (IVVD)vs › | $238.51M | 5.86 | 4.06 | 6.91 | 7.76 |
| High Tide Inc. (HITI)vs › | $237.69M | 0.81 | 0.81 | 0.76 | 0.71 |
| BioAge Labs Inc. (BIOA)vs › | $235.87M | 17.19 | 13.55 | 8.08 | 8.08 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.39M | 1.35 | 1.13 | 1.14 | 1.18 |
| Galectin Therapeutics Inc. (GALT)vs › | $241.04M | 0.10 | 1.46 | 1.56 | 2.73 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.79M | 44.27 | 28.93 | 23.00 | 20.76 |
| InflaRx N.V. (IFRX)vs › | $235.67M | 8.22 | 4.35 | 5.50 | 5.94 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.23M | 4.70 | 7.13 | 7.51 | 5.59 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | 2.69 | 2.01 | 1.61 | 1.29 |
Quick Ratio
20.30
Excludes inventory
Current Ratio
20.30
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 20.30 |
| 2026-03-31 | 5.33 |
| 2025-12-31 | 4.85 |
| 2025-09-30 | 4.57 |
| 2025-06-30 | 5.06 |
| 2025-03-31 | 4.71 |
| 2024-12-31 | 4.97 |
| 2024-09-30 | 6.53 |
| 2024-06-30 | 6.49 |
| 2024-03-31 | 4.19 |
| 2023-12-31 | 2.04 |
| 2023-09-30 | 0.54 |
| 2023-06-30 | 5.73 |
| 2023-03-31 | 8.30 |
| 2022-12-31 | 0.81 |
| 2022-09-30 | 8.44 |
| 2022-06-30 | 11.50 |
| 2022-03-31 | 12.62 |
| 2021-12-31 | 11.14 |
| 2021-09-30 | 10.25 |
| 2021-06-30 | 11.16 |
| 2021-03-31 | 10.76 |
| 2020-12-31 | 9.69 |
| 2020-09-30 | 10.55 |
| 2020-06-30 | 10.72 |
| 2020-03-31 | 13.66 |
| 2019-12-31 | 21.54 |
| 2019-09-30 | 14.67 |
| 2019-06-30 | 19.29 |
| 2019-03-31 | 10.80 |
| 2018-12-31 | 8.72 |
| 2018-09-30 | 13.24 |
| 2018-06-30 | 24.05 |
| 2018-03-31 | 12.75 |
| 2017-12-31 | 14.85 |
| 2017-09-30 | 0.00 |
